Global epidemiology of meningococcal disease LH Harrison, CL Trotter, ME Ramsay Vaccine 27, B51-B63, 2009 | 923 | 2009 |
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction CL Trotter, NJ Andrews, EB Kaczmarski, E Miller, ME Ramsay The Lancet 364 (9431), 365-367, 2004 | 720 | 2004 |
Meningococcal carriage by age: a systematic review and meta-analysis H Christensen, M May, L Bowen, M Hickman, CL Trotter The Lancet infectious diseases 10 (12), 853-861, 2010 | 684 | 2010 |
Efficacy of pneumococcal vaccination in adults: a meta-analysis A Huss, P Scott, AE Stuck, C Trotter, M Egger Cmaj 180 (1), 48-58, 2009 | 589 | 2009 |
Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis ME Ramsay, NJ Andrews, CL Trotter, EB Kaczmarski, E Miller Bmj 326 (7385), 365-366, 2003 | 512 | 2003 |
Increasing hospital admissions for pneumonia, England CL Trotter, JM Stuart, R George, E Miller Emerging infectious diseases 14 (5), 727, 2008 | 369 | 2008 |
Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study DM Daugla, JP Gami, K Gamougam, N Naibei, L Mbainadji, M Narbé, ... The Lancet 383 (9911), 40-47, 2014 | 293 | 2014 |
Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis HB Ferrer, C Trotter, M Hickman, S Audrey BMC public health 14 (1), 1-22, 2014 | 266 | 2014 |
The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection R Borrow, P Alarcón, J Carlos, DA Caugant, H Christensen, R Debbag, ... Expert review of vaccines 16 (4), 313-328, 2017 | 265 | 2017 |
Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs CL Trotter, MCJ Maiden Expert review of vaccines 8 (7), 851-861, 2009 | 241 | 2009 |
Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and … H Campbell, N Andrews, R Borrow, C Trotter, E Miller Clinical and Vaccine Immunology 17 (5), 840-847, 2010 | 240 | 2010 |
Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit SJ Gray, CL Trotter, ME Ramsay, M Guiver, AJ Fox, R Borrow, RH Mallard, ... Journal of medical microbiology 55 (7), 887-896, 2006 | 228 | 2006 |
A surveillance network for meningococcal disease in Europe CL Trotter, M Chandra, R Cano, A Larrauri, ME Ramsay, C Brehony, ... FEMS microbiology reviews 31 (1), 27-36, 2007 | 219 | 2007 |
Impact of MenAfriVac in nine countries of the African meningitis belt, 2010–15: an analysis of surveillance data CL Trotter, C Lingani, K Fernandez, LV Cooper, A Bita, C Tevi-Benissan, ... The Lancet infectious diseases 17 (8), 867-872, 2017 | 206 | 2017 |
Meningococcal carriage in the African meningitis belt CL Trotter, BM Greenwood The Lancet infectious diseases 7 (12), 797-803, 2007 | 206 | 2007 |
Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines CL Trotter, ME Ramsay FEMS microbiology reviews 31 (1), 101-107, 2007 | 206 | 2007 |
Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination CL Trotter, NJ Gay, WJ Edmunds American journal of epidemiology 162 (1), 89-100, 2005 | 196 | 2005 |
Neurodevelopmental impairment in children after group B streptococcal disease worldwide: systematic review and meta-analyses M Kohli-Lynch, NJ Russell, AC Seale, Z Dangor, CJ Tann, CJ Baker, ... Clinical Infectious Diseases 65 (suppl_2), S190-S199, 2017 | 183 | 2017 |
Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis H Fisher, CL Trotter, S Audrey, K MacDonald-Wallis, M Hickman International journal of epidemiology 42 (3), 896-908, 2013 | 167 | 2013 |
Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae CL Trotter, J McVernon, ME Ramsay, CG Whitney, EK Mulholland, ... Vaccine 26 (35), 4434-4445, 2008 | 161 | 2008 |